Studies have shown that ACLY is abnormally expressed in breast cancer, prostate cancer, bladder cancer, lung cancer, gastric cancer, liver cancer and colon cancer.27, 34, 35, 36, 37, 38, 39. Here, ACLY is linked to urinary bladder cancer.